A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

書誌詳細
第一著者:	Islam, Nahidul
その他の著者:	Talukder, Mesbah
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2023
主題:	Psoriasis Biologics FAERS Interleukin inhibitors Alopecia Pharmacovigilance
オンライン･アクセス:	http://hdl.handle.net/10361/22025

類似資料

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
著者:: Afroza, Halima
出版事項: (2024)

Biologics and Biosimilars as Treatment Options for Psoriasis
著者:: Moya, Amena Khatun
出版事項: (2023)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
著者:: Bishakha, Adwiza Chakraborty
出版事項: (2024)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
著者:: Islam, S.M. Zahidul
出版事項: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
著者:: Khandker, Tahia Anjum
出版事項: (2024)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
著者:: Onanna, Kazi
出版事項: (2024)

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
著者:: Nusrat, Tanzina
出版事項: (2019)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
著者:: Rahman, Ahadina
出版事項: (2018)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
著者:: Meem, Manila
出版事項: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
著者:: Islam, Saidul
出版事項: (2022)

A survey on the knowledge and attitude on pharmacovigilance among the pharmacy students of different universities of Dhaka, Bangladesh
著者:: Albee, Md. Hamza
出版事項: (2017)

Identification of FAP inhibitors using in silico simulation study
著者:: Deeba, Maliha Tasnim
出版事項: (2018)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
著者:: Karim, Azrin
出版事項: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
著者:: Jahan, Safrin
出版事項: (2023)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
著者:: Tabassum, Nadira
出版事項: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
著者:: Akter, Anika
出版事項: (2022)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
著者:: Shehab, Habibul Mohsin
出版事項: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
著者:: Haque, Mushfiqul
出版事項: (2019)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
著者:: Bakar, Osama Bin Abu
出版事項: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
著者:: Khan, Muidul Hasan
出版事項: (2024)

Biomarkers in the diagnosis and treatment of Covid-19
著者:: Kabir, Syeda Shuvessa
出版事項: (2023)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
著者:: Oshin, Sadia Afrin
出版事項: (2021)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
著者:: Mahin, Md. Tamjidur Rahman
出版事項: (2024)

Female Alopecia
著者:: TrÃ¼eb
出版事項: (2013)

RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
著者:: Rattry, Faria Rahman
出版事項: (2024)

Recent advancement of biologics in Asthma
著者:: Evan, Al- Shahriar
出版事項: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
著者:: Sorno, Rubina Haque
出版事項: (2024)

Cross-sectional survey to assess the knowledge, attitude and practice regarding adverse drug reactions of students of a private university
著者:: Islam, Tarikul
出版事項: (2021)

A study on drug product approval by the FDA from 1930 to 2019
著者:: Jony, Md. Nazmul Islam
出版事項: (2023)

Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
著者:: Hossain, Ragib
出版事項: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
著者:: Emon, Kamrul Hasan
出版事項: (2022)

FDA Consumer

FDA Consumer

FDA Consumer

FDA Consumer

Detection of skin diseases using deep learning
著者:: Shodoy, Masuk Ur Rahman
出版事項: (2024)

Assessment of knowledge and attitude of adverse Ddug reactions among healthcare professionals in Bangladesh
著者:: Paul, Sanjoy Kumer
出版事項: (2021)

Pharmacoepidemiology and Pharmacovigilance